The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment
Chronic hepatitis C (CHC) affects over 185 million individuals worldwide, approximately 3% of the world’s population. CHC can lead to quality of life impairment, cirrhosis, hepatocellular carcinoma (HCC), liver failure and liver-related death. While CHC has been associated with increases in HCC, liv...
Main Authors: | Brian P. Lam, Thomas Jeffers, Zahra Younoszai, Yousef Fazel, Zobair M. Younossi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-09-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756283X15587481 |
Similar Items
-
INTERFERON-FREE THERAPY FOR HEPATITIS C IN PAKISTAN
by: Dure Nayab, et al.
Published: (2017-03-01) -
Review: Treatment options for nonalcoholic fatty liver disease
by: Brian Lam, et al.
Published: (2010-03-01) -
Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection.
by: Vishnu Venugopal, et al.
Published: (2018-07-01) -
Interferons and hepatitis C virus
by: Markus H. Heim
Published: (2012-05-01) -
Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis
by: Michael Estep, et al.
Published: (2019-02-01)